Neonatal outcome of the pregnancies associated with placental villous thrombosis – thrombophilic status of the mothers and the infants

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Maternal-Fetal & Neonatal Medicine

• Publication date

  2012-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/14767058.2012.684169PMID 22524536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fetal placental thrombosis and neonatal implications.

  2010cited by this paper
• Placental histomorphology in unexplained foetal loss with thrombophilia.

  2009cited by this paper
• Placental pathology: a systematic approach with clinical correlations.

  2008cited by this paper
• Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes.

  2004cited by this paper
• Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy.

  2004cited by this paper
• Fetal thrombotic vasculopathy in the placenta: a thrombophilic connection between pregnancy complications and neonatal thrombosis?

  2004cited by this paper
• Placental pathology in fetal thrombophilia.

  2004cited by this paper
• Haemostatic mechanisms in human placenta.

  2003cited by this paper
• Antiphospholipid antibodies in women at risk for preeclampsia.

  2001cited by this paper
• Biparental contribution to fetal thrombophilia in discordant twin intrauterine growth restriction.

  2001cited by this paper
• Frequency of factor V(Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions.

  2000cited by this paper
• Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?

  2000cited by this paper
• Factor V1691 G-A, Prothrombin 20210 G-A, and Methylenetetrahydrofolate Reductase 677 C-T Variants in Turkish Children With Cerebral Infarct

  1999cited by this paper
• Prothrombin gene 20210 G‐A mutation in the Turkish population

  1998cited by this paper
• Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.

  1998cited by this paper
• Frequency of Factor V (1691 G → A) Mutation in Turkish Population

  1997cited by this paper
• A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies.

  1992cited by this paper
• Outcome of Treated Pregnancies in Women With Antiphospholipid Syndrome: An Update of the Utah Experience

  1992cited by this paper

• The Impact of Thrombophilia on Maternal and Neonatal Outcomes: A Multisystem Analysis of Clinical, Hematological, and Metabolic Parameters

  2025cites this paper
• Thrombophilia and newborn

  2024cites this paper
• Neonatal thrombosis

  2020cites this paper
• HISTOPATHOLOGICAL FEATURES OF TROPHOBLAST AND CHORIONIC VILLI IN THE PATIENTS WITH DEFICIENCY OF NATURAL ANTICOAGULANTS AND RECURRENT PREGNANCY LOSS

  2019cites this paper
• Fetal Thrombotic Vasculopathy

  2015cites this paper
• Gross Umbilical Cord Complications are Associated with Placental Lesions of Circulatory Stasis and Fetal Hypoxia

  2012cites this paper